Related Experiment Video
Updated: Jun 19, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Frequency of Pseudomonas aeruginosa colonizations/infections in lung transplant recipients
S Zeglen1, J Wojarski, E Wozniak-Grygiel
1Department and Clinic of Cardiac Surgery and Transplantology, Silesian Medical University, Zabrze, Poland. slawekzeglen@poczta.onet.pl
Background:
Lower respiratory tract infections remain a leading cause of morbidity and mortality after solid organ transplantation. The particularly increased susceptibility to infection is an especial problem in the early posttransplant period at the initial stage of immunosuppression, owing to direct contact with the hospital environment by mechanical ventilation, biopsies, injections, bronchoscopy, and bladder and vessel catheterizations exacerbated by the impaired clearance mechanisms after denervation of the transplanted lung. Airway colonization with Pseudomonas aeruginosa is common in lung transplant (LT) recipients. Therefore, we performed a retrospective analysis to address the frequency of P aeruginosa infections in our Center.
Materials And Methods:
From January 2004 to December 2008, we performed 33 LT, including 4 heart-lung, 6 double, and 23 single lung transplantations. Respiratory samples were the main diagnostic material undergoing routine microbiological methods.
Results:
P aeruginosa was isolated from 13 patients (39.4% of all 33 LT). In 10 cases (30.3%), we observed airway colonization together with lower respiratory tract infections. From 2005 to 2008, P aeruginosa was diagnosed in about 50% of LT patients each year: in 2005, 33.3%; 2006, 57.1%; 2007, 42.9%; and 2008, 40%.
Conclusion:
LT recipients in our center are at high risk for pseudomonal airway colonisation and lower respiratory tract infection that may have a significant impact on posttransplant follow-up.
Insights
Lung transplant recipients face a high risk of Pseudomonas aeruginosa infections. This study found nearly 40% of patients had P. aeruginosa, highlighting the need for vigilant post-transplant care.
Area of Science:
- Medical Microbiology
- Transplant Surgery
- Infectious Diseases
Background:
- Lower respiratory tract infections are a major cause of death post-solid organ transplant.
- Lung transplant recipients are especially vulnerable to infections early after surgery due to immunosuppression and invasive procedures.
- Airway colonization by Pseudomonas aeruginosa is frequent in lung transplant patients.
Purpose of the Study:
- To determine the frequency of Pseudomonas aeruginosa infections in lung transplant recipients at our center.
- To analyze the incidence of P. aeruginosa airway colonization and lower respiratory tract infections post-lung transplantation.
Main Methods:
- Retrospective analysis of 33 lung transplant (LT) cases performed between January 2004 and December 2008.
- Routine microbiological examination of respiratory samples.
- Inclusion of single, double, and heart-lung transplantations.
Main Results:
- Pseudomonas aeruginosa was isolated from 39.4% (13/33) of lung transplant recipients.
- Airway colonization with P. aeruginosa and subsequent lower respiratory tract infection occurred in 30.3% (10/33) of patients.
- The annual incidence of P. aeruginosa diagnosis ranged from 33.3% to 57.1% between 2005 and 2008.
Conclusions:
- Lung transplant recipients at this center exhibit a high risk of P. aeruginosa airway colonization and infection.
- Pseudomonas aeruginosa poses a significant threat to the post-transplant outcomes of lung transplant recipients.
- Early detection and management of P. aeruginosa are crucial for improving patient follow-up.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract
Atypical Pneumonia
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia III: Complications and Assessment

